Related Experiment Videos
Endogenous and exogenous interferons in HIV-infection
1Department of Interferons and Immunomodulators, D. Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kiev, 03143, Ukraine. karpov_av@hotmail.com
European Journal of Medical Research
|January 5, 2002
Summary
Interferons (IFNs) are key in fighting viral infections like human immunodeficiency virus (HIV). This review explores IFNs' dual role in HIV infection, detailing their induction, effects, and antiviral actions.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Interferons (IFNs) are crucial innate immune proteins involved in antiviral defense.
- Human immunodeficiency virus (HIV) infection poses a significant global health challenge.
- Understanding the complex interplay between IFNs and HIV is vital for therapeutic strategies.
Purpose of the Study:
- To review the current knowledge on the role of Type I and Type II interferons (IFNs) in human immunodeficiency virus (HIV) infection.
- To analyze endogenous IFNs induction by HIV and the characteristics of acid-labile IFNs.
- To examine the mechanisms of exogenous IFNs against HIV, including their positive and negative impacts.
Main Methods:
- Literature review of scientific articles and studies on interferons and HIV.
- Analysis of HIV-driven endogenous IFNs induction and exogenous IFNs mechanisms.
- Examination of IFN-inducible antiviral pathways and HIV's counter-defense mechanisms.
Main Results:
- HIV infection triggers endogenous IFNs induction and can lead to unusual acid-labile IFNs with clinical significance.
- Exogenous IFNs exhibit both beneficial and detrimental effects on HIV replication through various mechanisms.
- IFN-inducible pathways and enzymes (e.g., PKR, OAS, Mx) are involved in anti-HIV defense, but HIV develops resistance.
Conclusions:
- IFNs play a complex, multifaceted role in HIV infection, acting as both a defense mechanism and potentially exacerbating the disease.
- Further research into IFN-mediated pathways and HIV's evasion strategies is necessary for developing effective antiviral therapies.
- Targeting specific IFN-inducible antiviral mechanisms or modulating IFN responses could offer novel therapeutic avenues for HIV treatment.